Intravenous solutions provide essential macro- and micronutrients, electrolytes, and fluid to patients who suffer from dehydration due to diarrhea, vomiting, fever, or malnutrition. The solutions help restore hydration and energy levels in the body. With the rising prevalence of diarrhea caused by various bacterial and viral infections, there is an increasing need for intravenous solutions that can rapidly deliver hydration and vital nutrients to patients.
The global Intravenous Solutions Market is estimated to be valued at US$ 577228 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends propelling the growth of the intravenous solutions market is the increasing prevalence of diarrheal diseases worldwide. According to the World Health Organization (WHO), diarrhea is one of the leading causes of death among children under the age of five, responsible for killing around 525,000 children in 2017. Poor sanitation and lack of access to clean water in many developing regions have resulted in millions of cases of diarrhea each year. Severe diarrhea and subsequent dehydration often require IV rehydration therapy. The development of advanced intravenous solutions that offer rapid rehydration is helping to reduce mortality from diarrhea. Innovation in IV solution formulations to deliver hydration and nutrients more effectively is expected to drive the market over the forecast period.
Strength: The intravenous solutions market has strong growth potential owing to rising prevalence of chronic diseases and increasing number of surgical procedures performed globally.
Weakness: High costs associated with manufacturing and administration of intravenous solutions limit their use in resource poor settings.
Opportunity: Growing geriatric population that is more prone to chronic illnesses as well as emergence of new products with enhanced formulations present lucrative opportunities for market expansion.
Threats: Stringent regulations governing intravenous solutions and risks of infection associated with parenteral administration pose major challenges for market players.
The Global Intravenous Solutions Market Size is expected to witness high growth owing to increasing burden of chronic diseases combined with rising healthcare spending worldwide.
The North America region currently dominates the market due to high incidence of chronic conditions and technological advancements in parenteral drug delivery. Asia Pacific is projected to grow at the fastest rate during the forecast period. This can be attributed to rising healthcare infrastructure, growing medical tourism industry and increasing spending on chronic disease management in developing countries such as India and China.
Key players operating in the intravenous solutions market are Amara Halal Cosmetics, Andalou,Clara International Beauty Group, COSMECCA KOREA, COSRX, Ecotrail Personal Care Pvt. Ltd., Halal Korea Co., Ltd., INGLOT Cosmetics, INIKA organic, IVY Beauty Corporation, KOLMAR KOREA, SO.LEK Cosmetics, and Talent Cosmetics.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it